Paclitaxel
Janessa Smith, Pharm.D., BCPS, Paul A. Pham, Pharm.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Second-line treatment of AIDS-related Kaposi’s sarcoma
- Adjuvant therapy for node-positive breast cancer
- Second-line treatment of metastatic breast cancer
- First-line treatment of non-small cell lung cancer (in combination with cisplatin or carboplatin)
- Second-line treatment of metastatic ovarian cancer
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.